Fig. 5.
Fig. 5. Overall survival of all ALCL patients stratified according to CD56 expression and IPI category. / The CD56+ and IPI high-intermediate/high subgroups have an extremely poor prognosis (P < .0001).

Overall survival of all ALCL patients stratified according to CD56 expression and IPI category.

The CD56+ and IPI high-intermediate/high subgroups have an extremely poor prognosis (P < .0001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal